{"id":"W2781921947","doi":"10.1016/j.jaad.2018.01.003","title":"Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Secukinumab; Ixekizumab; Medicine; Interleukin 17; Psoriasis; Discontinuation; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Dermatology Life Quality Index; Ustekinumab; Plaque psoriasis; Anakinra; Placebo; Adalimumab; Psoriatic arthritis; Alternative medicine; Cytokine; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002917885,0.0002134369,0.001069972,0.0003945113,0.00007931585,0.000004099341,0.0004407162,0.0001144042,0.00001359607],"category_scores_gemma":[0.00009573976,0.0001331449,0.0001079924,0.0003950239,0.0007590532,0.00008666488,0.0001294531,0.0003880996,0.000001644757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006673037,"about_ca_system_score_gemma":0.00007343089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001760255,"about_ca_topic_score_gemma":0.0001312497,"domain_scores_codex":[0.9977756,0.0008053997,0.0008671543,0.0002049324,0.00009720405,0.0002496979],"domain_scores_gemma":[0.9977421,0.0003171065,0.001629718,0.00017286,0.0001077321,0.000030464],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08461088,0.002074264,0.5918834,0.0000531887,0.004342621,0.0000447441,0.06399013,0.00002144085,0.2379035,0.0001433821,0.0001976108,0.01473481],"study_design_scores_gemma":[0.01415023,0.004023207,0.8726479,0.0002735871,0.0003579977,0.001201797,0.01903307,0.000002868595,0.08784757,0.00004961626,0.0002422731,0.0001698416],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974025,0.0004273937,0.00004880861,0.001535886,0.0001543899,0.0003778389,0.0000158328,0.000004443422,0.00003288756],"genre_scores_gemma":[0.9994395,0.0001112547,0.0002498942,0.0001431237,0.0000232796,0.000004759568,4.904672e-7,0.00001592125,0.00001173441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2807645,"threshold_uncertainty_score":0.5429493,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01177768967492962,"score_gpt":0.2791067948025814,"score_spread":0.2673291051276518,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}